Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found that certain RNA sequences play a role in yak hair growth and these sequences are somewhat similar to those in cashmere goats.

A new mutation in the CDH3 gene causes hair loss and vision problems in a young girl.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

Testosterone changes how certain channels work in male rat reproductive tracts, affecting fertility-related fluid balance.

Both HLA-B and MICA are independently linked to alopecia areata.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

People with androgenetic alopecia may have a higher risk of severe COVID-19.

pCLCA2 protein may help maintain skin structure and function.

Retinoic acid, glucocorticoids, and IGF1 increase IGFBP-3 production in human dermal papilla cells, affecting hair growth.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

KGF and activin are crucial for skin healing and repair.

Fat tissue stem cells may help increase hair growth.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Lgr5 is a marker for active, long-lasting stem cells in mouse hair follicles.

TRPA1 is crucial for mechanical sensitivity in skin sensory neurons.

The hedgehog signaling pathway is crucial for hair growth but not for the initial creation of hair follicles.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Applying a special compound can promote hair growth without harmful side effects.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

AGA linked to worse COVID-19 outcomes in men.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Activin activation in skin cells speeds up wound healing without affecting scar quality.

Having a lot of gray hair and hair loss are linked to more severe COVID-19.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.